SAGA Diagnostics to Present Data on Ultrasensitive PathlightTM MRD Test in Breast, Colon, and Rectal Cancers at ASCO 2026

MORRISVILLE, N.C.--(BUSINESS WIRE)-- #ASCO2026--SAGA will present new data supporting Pathlight, its tumor-informed, structural variant-based ctDNA platform, across metastatic and localized cancers.